Ecor1 Capital Fund Qualified, L.p.

Affiliations

  • Director at Nuvation Bio Inc. (NUVB), 2023-09-22
  • Large Shareholder, Director at Panacea Acquisition Corp. Ii (PANA), 2023-05-02
  • Large Shareholder at Kura Oncology Inc. (KURA), 2019-01-10
  • Large Shareholder at Atyr Pharma Inc (LIFE), 2018-05-16
  • Large Shareholder at Assembly Biosciences Inc. (ASMB), 2018-04-18
  • Other at Genvec Inc (GNVC), 2014-05-27
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
KURA $13.16 83,540 $1,099,386.40 4,408,097 2018-12-21 Filing
KURA $13.84 51,879 $718,005.36 4,324,557 2018-12-19 Filing
KURA $13.82 78,469 $1,084,441.58 4,272,678 2018-12-18 Filing
KURA $13.89 25,217 $350,264.13 4,220,729 2018-12-13 Filing
KURA $13.91 15,321 $213,098.26 4,195,512 2018-12-11 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
KURA $13.20 26,520 $350,064.00 4,194,209 2018-12-17 Filing
LIFE $0.81 2,733,231 $2,216,923.66 0 2018-05-16 Filing
LIFE $1.43 121,294 $173,062.28 2,733,231 2018-05-15 Filing
LIFE $1.72 354,791 $609,069.71 2,854,525 2018-05-14 Filing
ATYR $3.95 1,083 $4,277.85 3,209,316 2017-11-13 Filing